Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Test-Negative Case-control Study to Evaluate the Effectiveness of VLA1553 Against Chikungunya Virus Disease During a Pilot Vaccination Strategy in Brazil

NCT07347002 is registered in ClinicalTrials.gov with Valneva Austria GmbH as lead sponsor.

NCT NCT07347002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07347002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Test-Negative Case-control Study to Evaluate the Effectiveness of VLA1553 Against Chikungunya Virus Disease During a Pilot Vaccination Strategy in Brazil
Lead sponsor
Valneva Austria GmbH
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 2, 2026
Completion date
December 31, 2027
Enrollment
1,200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chikungunya virus infection